Research Article

Antibacterial and Antioxidant Efficacies of Secondary Metabolites from the Roots of Cyphostemma adenocaule: A Combined In Vitro and In Silico Study

Table 1

Inhibition zone (mean ± SD, in mm) of CH2Cl2 : MeOH (1 : 1) extract and the isolated compounds (16).

Bacterial strainConc. (mg/mL)Average inhibition zone (mm) (3 trials)
CH2Cl2 : MeOH extract123456Ciprofloxacin (30 μg/disc)

E. coli218.00 ± 0.0012.67 ± 0.4713.50 ± 0.8714.30 ± 0.4714.67 ± 0.4716.17 ± 0.2415.33 ± 0.2421.33 ± 0.47
114.50 ± 0.4110.50 ± 0.4111.33 ± 0.4711.67 ± 0.4712.00 ± 0.0013.50 ± 0.4112.50 ± 0.41
0.511.50 ± 0.419.33 ± 0.479.50 ± 0.009.83 ± 0.2410.00 ± 0.0011.33 ± 0.4710.50 ± 0.41
0.259.83 ± 0.247.00 ± 0.007.67 ± 0.478.83 ± 0.249.00 ± 0.009.83 ± 0.249.67 ± 0.47

S. aureus217.16 ± 0.2411.83 ± 0.2413.33 ± 0.4714.00 ± 0.0014.33 ± 0.4716.67 ± 0.4715.33 ± 0.4721.50 ± 0.41
113.83 ± 0.249.83 ± 0.2410.16 ± 0.2411.33 ± 0.4711.50 ± 0.4112.67 ± 0.4711.67 ± 0.47
0.511.00 ± 0.008.16 ± 0.248.50 ± 0.419.33 ± 0.479.50 ± 0.4110.00 ± 0.009.67 ± 0.47
0.259.50 ± 0.41NA7.33 ± 0.478.16 ± 0.248.33 ± 0.479.33 ± 0.478.83 ± 0.24

P. aeruginosa215.67 ± 0.4712.00 ± 0.0012.50 ± 0.4114.16 ± 0.2413.16 ± 0.2412.67 ± 0.4713.83 ± 0.2420.00 ± 0.81
112.00 ± 0.009.33 ± 0.4710.16 ± 0.2411.50 ± 0.4110.83 ± 0.2410.33 ± 0.4711.16 ± 0.24
0.510.16 ± 0.248.00 ± 0.008.83 ± 0.2410.00 ± 0.009.33 ± 0.479.16 ± 0.249.50 ± 0.41
0.258.50 ± 0.00NA7.16 ± 0.248.33 ± 0.477.67 ± 0.477.33 ± 0.478.00 ± 0.00

S. pyogenes216.33 ± 0.4712.50 ± 0.4112.83 ± 0.2415.33 ± 0.4714.50 ± 0.0013.67 ± 0.4713.83 ± 0.2421.00 ± 0.81
113.16 ± 0.249.67 ± 0.4710.00 ± 0.0011.67 ± 0.4711.33 ± 0.4710.67 ± 0.4710.83 ± 0.24
0.510.83 ± 0.248.33 ± 0.478.67 ± 0.4710.16 ± 0.249.50 ± 0.009.00 ± 0.009.16 ± 0.24
0.259.50 ± 0.417.16 ± 0.247.33 ± 0.479.00 ± 0.818.67 ± 0.477.83 ± 0.248.00 ± 0.81

CH2Cl2, dichloromethane; MeOH, methanol; NA, no activity; SD, standard deviation. For CH2Cl2 : MeOH (1 : 1) extract, 2: 50 mg/mL, 1: 25 mg/mL, 0.5: 12.5 mg/mL, and 0.25: 6.25 mg/mL.